Cargando…

Incidence of Major Bleeding in Patients with Pulmonary Thromboembolism Treated with Fixed Dose Alteplase 100 mg

BACKGROUND: Acute pulmonary thromboembolism (PTE) is a critical cardiopulmonary condition associated with high mortality and morbidity. In massive PTE, recently referred to as high risk PTE, the routine protocol for thrombolysis with recombinant tissue plasminogen activator (alteplase) is 100 mg ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Dae-Hwan, Lee, Won Jae, Shin, Yoon Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445310/ https://www.ncbi.nlm.nih.gov/pubmed/32830464 http://dx.doi.org/10.3346/jkms.2020.35.e267

Ejemplares similares

Pharmacokinetic Interaction Between Isavuconazole and a Fixed‐Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects
por: Yamazaki, Takao, et al.
Publicado: (2016)

Short‐course intrapleural alteplase and DNase in complex effusion with bleeding risk
por: Cheong, Xiong Khee, et al.
Publicado: (2020)

Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination
por: Kim, Hyun Chul, et al.
Publicado: (2022)

Determinants for a low dose of alteplase and its relationship to a lower intracerebral bleeding risk in acute ischemic stroke
por: Chen, Jie, et al.
Publicado: (2022)

Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin
por: Lai, Hoang M, et al.
Publicado: (2009)

Hardness, function, emotional well-being, satisfaction and the overall sexual experience in men using 100-mg fixed-dose or flexible-dose sildenafil citrate
por: Ströberg, P, et al.
Publicado: (2010)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

Use of carefully titrated ultra‐low doses of alteplase in infected haemothorax caused by initial alteplase use to drain loculated malignant pleural effusion
por: Oh, Jeong Suk, et al.
Publicado: (2023)

Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2020)

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
por: Demelo-Rodriguez, Pablo, et al.
Publicado: (2023)

Low dose Mifepristone (100 mg) for medical termination of pregnancy
por: Seth, Shikha, et al.
Publicado: (2011)

Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy
por: Wells, Philip S, et al.
Publicado: (2014)

Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects
por: Hwang, Inyoung, et al.
Publicado: (2018)

Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke: The ENCHANTED Trial
por: Zhou, Zien, et al.
Publicado: (2021)

THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial
por: Koga, Masatoshi, et al.
Publicado: (2014)

Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial
por: Koga, Masatoshi, et al.
Publicado: (2020)

Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
por: Okada, Takashi, et al.
Publicado: (2022)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
por: Johnsen, Håkon S., et al.
Publicado: (2019)

Correlation of effectiveness and tolerability assessments from a pharmacy-based observational study investigating the fixed-dose combination of 400 mg ibuprofen plus 100 mg caffeine for the treatment of acute headache
por: Gaul, Charly, et al.
Publicado: (2023)

Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism
por: Ferrazzini, Elisa, et al.
Publicado: (2022)

Fed and fasted bioequivalence assessment of two formulations of extended-release fixed-dose combination dapagliflozin/metformin (10/1,000 mg) tablets in healthy subjects
por: Lee, Hae Won, et al.
Publicado: (2023)

Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects
por: Lee, Hae Won, et al.
Publicado: (2020)

Low-dose vs. standard-dose intravenous alteplase for acute ischemic stroke with unknown time of onset
por: Wang, Zekun, et al.
Publicado: (2023)

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder
por: Katzman, Martin A., et al.
Publicado: (2017)

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding
por: Kline, Jeffrey A., et al.
Publicado: (2016)

The incidence of venous thromboembolism is not lowin Korean patients with advanced pancreatic cancer
por: Yoon, Seug Yun, et al.
Publicado: (2018)

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Trajectories of adherence to extended treatment with warfarin and risks of recurrent venous thromboembolism and major bleeding
por: Kang, Hye-Rim, et al.
Publicado: (2023)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
por: Singh, Nishita, et al.
Publicado: (2023)

Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time
por: McCartney, Peter J., et al.
Publicado: (2020)

Systemic reduced‐dose alteplase for diffuse pulmonary thrombi in a COVID‐19 patient
por: Colkesen, Yucel
Publicado: (2023)

Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial
por: Koga, Masatoshi, et al.
Publicado: (2023)

Gastrointestinal bleed induced by a fixed dose combination of rabeprazole and diclofenac sodium
por: Tandon, Vishal R., et al.
Publicado: (2014)

Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis
por: Lovely, Jenna K., et al.
Publicado: (2020)

Risk Factors of Unfavorable Outcomes, Major Bleeding, and All-Cause Mortality in Patients with Venous Thromboembolism
por: Lee, Han Young, et al.
Publicado: (2021)

Low dose intrapleural alteplase and pulmozyme (DNase) in two post-surgical patients with pleural sepsis
por: Faisal, M., et al.
Publicado: (2020)

Low versus standard dose intravenous alteplase in the treatment of acute ischemic stroke in Egyptian patients
por: Salem, Gelan M., et al.
Publicado: (2021)

Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction
por: Ahn, Sun Tae, et al.
Publicado: (2020)

Clinical experience with alteplase in the management of intracardiac and major cardiac vessels thrombosis in pediatrics: a case series
por: Al-Jazairi, Abdulrazaq S., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_04a1s7t7ghbovcpjpscniaki7c